Alkeon Capital Management - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$214,335,000
+36.8%
1,245,412
-0.2%
0.36%
+56.7%
Q2 2021$156,628,000
-32.9%
1,248,131
-27.5%
0.23%
-33.4%
Q1 2021$233,484,000
+6.2%
1,721,731
+0.2%
0.35%
-3.1%
Q4 2020$219,855,000
+20.2%
1,718,421
+5.7%
0.36%
+5.6%
Q3 2020$182,929,000
+28.0%
1,625,606
+8.3%
0.34%
-6.4%
Q2 2020$142,963,000
+15.4%
1,500,606
+8.9%
0.36%
-31.6%
Q1 2020$123,836,000
+304.1%
1,377,950
+138.4%
0.53%
+364.0%
Q4 2019$30,643,000
-17.8%
577,950
-38.8%
0.11%
-13.0%
Q3 2019$37,295,000
-3.8%
943,9500.0%0.13%
-14.9%
Q2 2019$38,778,000
-1.3%
943,950
+11.8%
0.15%
-21.4%
Q1 2019$39,303,000
+141.3%
843,950
+125.7%
0.20%
+84.9%
Q4 2018$16,286,000
+4.5%
373,950
+37.3%
0.11%
+43.2%
Q3 2018$15,585,000272,3290.07%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,505,012$204,095,00039.96%
Foresite Capital Management III, LLC 108,630$14,731,00012.94%
Avoro Capital Advisors LLC 3,000,000$406,830,0007.03%
Octagon Capital Advisors LP 112,363$15,238,0005.74%
Artal Group S.A. 1,400,000$189,854,0003.36%
Eversept Partners, LP 241,981$32,815,0432.47%
NWI MANAGEMENT LP 200,000$27,122,0002.26%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 60,500$8,199,0002.17%
Affinity Asset Advisors, LLC 45,000$6,102,0002.07%
Parkman Healthcare Partners LLC 62,780$8,514,0001.98%
View complete list of ACCELERON PHARMA INC shareholders